INS and Alzheimer disease: Recent studies have delineated that impaired insulin signaling and resistance to insulin or glucose uptake in the brain are strongly associated with the pathogenesis of AD (Talbot et al., 2012; De Felice et al., 2014; Willette et al., 2015).